Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
about
Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic EffectivenessSOX2 enhances the migration and invasion of ovarian cancer cells via Src kinasePTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.Pathways driving the endocytosis of mutant and wild-type EGFR in cancer.Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathwayProtein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast CancerHER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain.Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models.PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.Regulation of Apoptosis by HER2 in Breast Cancer.Hyaluronan expression in primary and secondary brain tumors.HDACIs and the inhibition of invasive potential.Trastuzumab-modified DM1-loaded nanoparticles for HER2+ breast cancer treatment: an in vitro and in vivo study.Novel inhibitors of breast cancer relevant kinases Brk and HER2
P2860
Q26827815-F01B08A8-7610-42BD-BB52-45C71289AA64Q33768815-9FC8F0AE-79B5-4D27-BD78-F2E795DC0625Q34227580-DC61C0E6-1C00-4A30-8B77-DF8B7644D211Q34781357-29D73002-E3E0-477F-9584-2CBE735C63EEQ34912116-104B546A-50FB-4808-978D-72FA3EFBB275Q35154495-A7AAA59E-55F7-44DF-805C-1966F9A2E4B0Q36022273-0CD9594C-8907-469C-A747-FFEC150999A6Q36693131-ED059B9D-C5C3-4AD0-AF9C-92B74BDEB4ADQ36989525-5B98515B-9465-48D7-9E98-E55933D2FE24Q37577818-202341D4-26CE-44B6-B056-9093EE0D9093Q37614521-3D20F0FC-71F1-41C4-8816-040A2ED0390CQ38731998-FFE8257D-79B7-499B-8CE7-20E0B667002AQ39125642-F11AC524-C373-42CD-84BC-2385EFDA2E02Q39843650-48BA1914-49FD-4BCB-AC8C-C455FE57BBBCQ40169267-D3FB1D8C-C723-407F-B1E9-FE10CD185DEFQ41905188-70B0FE26-11C5-4891-9671-30D2CE7BAA2BQ50083411-D677AF3D-2563-4DCA-AA79-E42FC60C671CQ58860058-1BFF9A99-5F6A-4C87-9BA8-E848988609A2
P2860
Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@ast
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@en
type
label
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@ast
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@en
prefLabel
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@ast
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@en
P2093
P2860
P356
P1476
Brk/PTK6 cooperates with HER2 ...... ial-to-mesenchymal transition.
@en
P2093
P2860
P304
P356
10.4161/CBT.23295
P577
2013-01-04T00:00:00Z